Published by Global Banking & Finance Review®
Posted on December 9, 2024
1 min readLast updated: January 27, 2026
Add as preferred source on Google
CompuGroup Medical is negotiating a 1.14 billion euro acquisition by CVC Capital Partners, with shares priced at 22 euros each.
(Reuters) - CompuGroup Medical, a German provider of healthcare software, said on Sunday it is in advanced talks to be acquired by CVC Capital Partners for a potential 22 euros ($23.24) per share.
The deal is worth 1.14 billion euros based on CompuGroup's 51.7 million shares outstanding, Reuters' calculations showed. Its shares closed at 16 euros on Friday.
CompuGroup shareholders centered around the founding Gotthardt family would retain a stake of around 50.1% after a strategic partnership with CVC, a private equity firm, is established, CompuGroup said in a statement.
CompuGroup shares would be delisted later, it added.
Bloomberg News reported on the talks earlier on Sunday.
CompuGroup shares fell to a 10-year low after the company, whose software is used to manage patient data, cut its fiscal 2024 guidance in July. The stock has fallen more than 55% year to date.
CompuGroup, based in Koblenz, Germany, posted revenue of 283.4 million euros in the third quarter.
($1 = 0.9466 euros)
(Reporting by Disha Mishra in Bengaluru and Urvi Dugar; Editing by Lisa Shumaker and Richard Chang)
The main topic is the potential acquisition of CompuGroup Medical by CVC Capital Partners.
The deal is valued at 1.14 billion euros, with shares priced at 22 euros each.
The Gotthardt family will retain a 50.1% stake after the acquisition.
Explore more articles in the Finance category
